Lion Point Capital, LP Q1 2025 Filing

Filed May 15, 2025

Portfolio Value

$15.7B

Holdings

21

Report Date

Q1 2025

Filing Type

13F-HR

All Holdings (21 positions)

#StockSharesValue% PortfolioType
1
IM8NINSMED INC
30,500$2.3B14.84%
2
ARDXARDELYX INC
335,400$1.6B10.51%
3
MLYSMINERALYS THERAPEUTICS INC
79,000$1.3B8.00%
4
FRXFENNEC PHARMACEUTICALS INC
195,700$1.2B7.60%
5
KNSAKINIKSA PHARMACEUTICALS LTD
45,900$1.0B6.50%
6
BBIOBRIDGEBIO PHARMA INC
26,000$898.8M5.73%
7
BNTCBENITEC BIOPHARMA INC
62,000$806.6M5.15%
8
GONGERON CORP
500,000$795.0M5.07%
9
AVDLAVADEL PHARMACEUTICALS PLC
98,700$772.8M4.93%
10
ARQTARCUTIS BIOTHERAPEUTICS INC
46,300$724.1M4.62%
11
SNDXSYNDAX PHARMACEUTICALS INC
55,000$675.7M4.31%
12
JSPRJASPER THERAPEUTICS INC
146,500$630.0M4.02%
13
BHVNBIOHAVEN LTD
22,700$545.7M3.48%
14
IRONDISC MEDICINE INC
10,600$526.2M3.36%
15
MISTMILESTONE PHARMACEUTICALS IN
548,806$439.1M2.80%
16
RGNXREGENXBIO INC
57,750$412.9M2.63%
17
BLE0BLUEBIRD BIO INC
78,912$385.1M2.46%
18
MCRB1EURSERES THERAPEUTICS INC
340,761$238.5M1.52%
19
MERSANA THERAPEUTICS INC
644,000$221.7M1.41%
20
HUMAHUMACYTE INC
83,500$142.4M0.91%
21
SPRBSPRUCE BIOSCIENCES INC
75,000$21.8M0.14%